Low‐Dose Nebulised Epoprostenol in the Management of Acute Respiratory Distress Syndrome

Publisher： John Wiley & Sons Inc

E-ISSN： 2055-2335|41|1|45-48

ISSN： 1445-937x

Source： JOURNAL OF PHARMACY PRACTICE AND RESEARCH, Vol.41, Iss.1, 2011-03, pp. : 45-48

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacotherapy of acute respiratory distress syndrome

By Santos CC dos   Slutsky AS   Chant C  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 7, 2002-07 ,pp. : 875-888

Informa Healthcare

Access to resources Recommend Favorite

Lithium: Acute respiratory distress syndrome: case report

By  

Reactions Weekly, Vol. 1, Iss. 1352, 2011-01 ,pp. : 25-25

Adis International

Access to resources Recommend Favorite

Acute respiratory distress syndrome following treatment for babesiosis

By Jr Ryland P Byrd   Roy Thomas M  

Expert Opinion on Pharmacotherapy, Vol. 3, Iss. 11, 2002-11 ,pp. : 1541-1542

Informa Healthcare

Access to resources Recommend Favorite

The acute respiratory distress syndrome: recent advances in ventilation

By Johnston Darryl   Brett Stephen  

Clinical Medicine, Vol. 2, Iss. 2, 2002-03 ,pp. : 104-108

Royal College Of Physicians

Access to resources Recommend Favorite

Emerging therapies for treatment of acute lung injury and acute respiratory distress syndrome

By Bosma Karen J   Lewis James F  

Expert Opinion on Emerging Drugs, Vol. 12, Iss. 3, 2007-09 ,pp. : 461-477

Informa Healthcare

Access to resources Recommend Favorite